GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (OTCPK:DTCFF) » Definitions » Tax Rate %

Defence Therapeutics (Defence Therapeutics) Tax Rate % : 0.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Defence Therapeutics's Tax Expense for the three months ended in Mar. 2024 was $0.00 Mil. Defence Therapeutics's Pre-Tax Income for the three months ended in Mar. 2024 was $-0.98 Mil. Therefore, Defence Therapeutics's Tax Rate % for the quarter that ended in Mar. 2024 was 0.00%.

Defence Therapeutics Tax Rate % Historical Data

The historical data trend for Defence Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Tax Rate % Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
Tax Rate %
- - -

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Defence Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Defence Therapeutics's Tax Rate % for the fiscal year that ended in Jun. 2022 is calculated as

Tax Rate %=Tax Expense (A: Jun. 2022 )/Pre-Tax Income (A: Jun. 2022 )
=0/-5.736
=0.00 %

Defence Therapeutics's Tax Rate % for the quarter that ended in Mar. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2024 )/Pre-Tax Income (Q: Mar. 2024 )
=0/-0.981
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Defence Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (Defence Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (OTCPK:DTCFF) » Definitions » Tax Rate %
Comparable Companies
TSX:EPRX NEOE:MMED TSXV:NGEN TSX:BCT TSX:ONC XCNQ:MSET TSXV:ARCH TSXV:MIR TSXV:DMT TSX:HBP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
DTC:Germany DTC:Canada
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Website
https://www.defencetherapeutics.com
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Defence Therapeutics (Defence Therapeutics) Headlines

No Headlines